PULSED-MULTILINE EXCITATION FOR COLOR-BLIND FLUORESCENCE DETECTION

• US 20090156429A1
• Filed: 02/18/2009
• Published: 06/18/2009
• Est. Priority Date: 08/28/2001
• Status: Active Grant

• Current Assignee: Carter Kittrell, Graham B.I. Scott, Michael Metzker, Robert F. Curl
• Original Assignee: Carter Kittrell, Graham B.I. Scott, Michael Metzker, Robert F. Curl
• Inventors: Scott, Graham B.I., Metzker, Michael, Curl, Robert F., Kittrell, Carter
• Granted Patent: US 8,089,628 B2
• Time in Patent Office: Days
• US Class Current: 506/12
• CPC Class Codes: G01J 3/021 using plane or convex mirrors, parallel phase plates, or particular reflectors
• CPC Class Codes: G01J 3/10 Arrangements of light sources specially adapted for spectrometry or colorimetry
• CPC Class Codes: G01J 3/4406 Fluorescence spectrometry
• CPC Class Codes: G01N 2021/6419 Excitation at two or more wavelengths
• CPC Class Codes: G01N 2021/6441 with two or more labels
• CPC Class Codes: G01N 21/6428 Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" in vivo A61B5/00; immunoassay G01N33/53
• CPC Class Codes: G01N 21/6458 Fluorescence microscopy fluorescence microscopes per se G02B21/0076 and G02B21/16

Abstract

The present invention provides a technology called Pulse-Multiline Excitation or PME. This technology provides a novel approach to fluorescence detection with application for high-throughput identification of informative SNPs, which could lead to more accurate diagnosis of inherited disease, better prognosis of risk susceptibilities, or identification of sporadic mutations. The PME technology has two main advantages that significantly increase fluorescence sensitivity: (1) optimal excitation of all fluorophores in the genomic assay and (2) “color-blind” detection, which collects considerably more light than standard wavelength resolved detection. Successful implementation of the PME technology will have broad application for routine usage in clinical diagnostics, forensics, and general sequencing methodologies and will have the capability, flexibility, and portability of targeted sequence variation assays for a large majority of the population.

Claims

1. A method of identifying sample components comprising:

(a) obtaining a biological sample;

(b) labeling said sample with one or more fluorophores;

(c) separating components of said sample; and

(d) detecting said sample components with a device wherein said device comprises;

one or more lasers configured to emit two or more excitation lines, each excitation line having a different excitation wavelength;

a timing circuit coupled to the one or more lasers and configured to fire the two or more excitation lines sequentially according to a timing program to produce time-correlated fluorescence emission signals from the sample; and

a non-dispersive detector positioned to collect the time-correlated fluorescence emission signals;

wherein said detector collects time correlated data from said sample comprising fluorescent emissions of the sample as a result of irradiation by the one or more excitation lines.

2. The method of claim 1, wherein said sample components are nucleic acids.

3. The method of claim 1, wherein said sample components are amino acids.

4. The method of claim 1, wherein said sample components are proteins.

5. The method of claim 1, wherein said separating is by electrophoresis.

6. The method of claim 1, wherein said separating is by chromatography.

7. The method of claim 1, wherein said separating is by mass spectrometry.

8. The method of claim 1, wherein said sample components are addressed on high density chip arrays.

9. The method of claim 1, further comprising:

(e) contacting said sample components on a surface comprising immobilized oligonucleotides at known locations on said surface; and

(f) performing a single nucleotide incorporation assay.

10. The method of claim 1, further comprising:

(e) contacting said sample components on a surface comprising immobilized oligonucleotides at known locations on said surface; and

(f) performing a mini-sequencing assay.

11. The method of claim 9, further comprising rastering said surface or said excitation lines such that said excitation lines contact said surface at multiple locations.